[Report of colorectal cancer incidence and mortality in China, 2013]
- PMID: 28926901
- DOI: 10.3760/cma.j.issn.0253-3766.2017.09.012
[Report of colorectal cancer incidence and mortality in China, 2013]
Abstract
Objective: To estimate the incidence and mortality of colorectal cancer (CRC) in China, providing basic information of treatment and prevention in CRC. Methods: In 2016, National Central Cancer Registry (NCCR) collected registration data in 2013 from local cancer registries and assessed the data according to the auditing methods and evaluation criteria formulated by NCCR. 347 cancer registries submitted data of 2013 to NCCR. Qualified data from 255 registries was pooled, analyzed and stratified by area (urban/rural), gender, and age. CRC incidence and mortality were estimated using national population in 2013. Results: In 2013, the estimate of new cases diagnosed with CRC in China was 347.9 thousands, with 9.45% of new cancer cases. The crude incidence of CRC was 25.57/100, 000 (28.64/100, 000 for male and 22.34/100, 000 for female, 30.92/100, 000 in urban areas and 19.35/100, 000 in rural areas), ranking fourth in all cancer. The age-standardized rates by China population and by world population were 17.45/100, 000 and 17.20/100, 000, respectively. Cumulative incidence of CRC in China was 2.05%. The estimated CRC deaths of China was 164, 900 in 2013, accounting for 7.39% of overall cancer deaths. The crude mortality rate for CRC was 12.11/100, 000 (13.49/100, 000 for male and 10.67/100, 000 for female, 14.41/100, 000 in urban and 9.45/100, 000 in rural), ranking fifth in all cancer. The age-standardized rates by China population and by World population for mortality were 7.87/100, 000 and 7.76/100, 000, respectively. Cumulative mortality rate of CRC in China was 0.82%. For both of incidence and mortality, males had much higher rates than females, while urban areas had much higher rates than rural areas. The incidence and mortality rates of CRC increased greatly with age, especially after 35 or 40 years old, and reached the peak in the age group of 80 or 85+ year old. Conclusion: The disease burden of CRC was still serious in China. Primary prevention and early detection of CRC in China is crucial.
目的: 了解2013年中国结直肠癌的发病与死亡情况,为结直肠癌的防治提供基础信息。 方法: 提取2016年全国肿瘤登记中心收集的2013年中国肿瘤登记地区的肿瘤登记资料,按照全国肿瘤登记中心制订的审核方法和评价标准对347个肿瘤登记地区的数据进行评估,其中255个登记地区的数据符合入选标准。按地区(城乡)、性别、年龄别,结合2013年全国人口数据,估计2013年全国结直肠癌的发病与死亡情况。 结果: 全国2013年新发结直肠癌病例数约为34.79万例,占全部恶性肿瘤发病的9.45%,位居恶性肿瘤发病的第4位。全国结直肠癌粗发病率为25.57/10万,其中男性为28.64/10万,女性为22.34/10万,中国人口标化发病率(中标率)为17.45/10万,世界人口标化发病率(世标率)为17.20/10万,累积发病率为2.05%。城市地区发病率为30.92/10万,农村地区发病率为19.35/10万。2013年全国结直肠癌死亡病例数约为16.49万例,占全部恶性肿瘤死亡的7.39%,位居恶性肿瘤死亡的第5位。结直肠癌粗死亡率为12.11/10万,其中男性为13.49/10万,女性为10.67/10万,中标死亡率为7.87/10万,世标死亡率为7.76/10万,累积死亡率为0.82%。城市地区死亡率为14.41/10万,农村地区死亡率为9.45/10万。结直肠癌的发病率和死亡率均为男性高于女性,城市高于农村,年龄别发病率和死亡率以35岁或40岁之后快速增长,至80岁或85岁以上达到高峰。 结论: 中国结直肠癌的疾病负担仍然较重,结直肠癌的早期发现和尽早预防至关重要。.
Keywords: China; Colorectal neoplasms; Incidence; Mortality.
Similar articles
-
[Incidence and mortality of stomach cancer in China, 2013].Zhonghua Zhong Liu Za Zhi. 2017 Jul 23;39(7):547-552. doi: 10.3760/cma.j.issn.0253-3766.2017.07.015. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 28728305 Chinese.
-
[Incidence and mortality of female breast cancer in China, 2014].Zhonghua Zhong Liu Za Zhi. 2018 Mar 23;40(3):166-171. doi: 10.3760/cma.j.issn.0253-3766.2018.03.002. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29575833 Chinese.
-
[Incidence and mortality of laryngeal cancer in China, 2014].Zhonghua Zhong Liu Za Zhi. 2018 Oct 23;40(10):736-743. doi: 10.3760/cma.j.issn.0253-3766.2018.10.004. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 30392337 Chinese.
-
National and subnational incidence, mortality and associated factors of colorectal cancer in China: A systematic analysis and modelling study.J Glob Health. 2023 Oct 13;13:04096. doi: 10.7189/jogh.13.04096. J Glob Health. 2023. PMID: 37824177 Free PMC article.
-
Cancer registration in China and its role in cancer prevention and control.Lancet Oncol. 2020 Jul;21(7):e342-e349. doi: 10.1016/S1470-2045(20)30073-5. Lancet Oncol. 2020. PMID: 32615118 Review.
Cited by
-
[Changing Epidemic of Lung Cancer & Tobacco and Situation of Tobacco Control in China].Zhongguo Fei Ai Za Zhi. 2017 Aug 20;20(8):505-510. doi: 10.3779/j.issn.1009-3419.2017.08.01. Zhongguo Fei Ai Za Zhi. 2017. PMID: 28855029 Free PMC article. Review. Chinese.
-
[Role of PD 0332991 on the Proliferation and Apoptosis of Vascular Endothelial Cells].Zhongguo Fei Ai Za Zhi. 2018 May 20;21(5):375-382. doi: 10.3779/j.issn.1009-3419.2018.05.04. Zhongguo Fei Ai Za Zhi. 2018. PMID: 29764587 Free PMC article. Chinese.
-
A meta-analysis of the relationship between environmental tobacco smoke and lung cancer risk of nonsmoker in China.Medicine (Baltimore). 2018 Jul;97(28):e11389. doi: 10.1097/MD.0000000000011389. Medicine (Baltimore). 2018. PMID: 29995781 Free PMC article. Review.
-
Prognostic factors and therapeutic effects of different treatment modalities for colorectal cancer liver metastases.World J Gastrointest Oncol. 2020 Oct 15;12(10):1177-1194. doi: 10.4251/wjgo.v12.i10.1177. World J Gastrointest Oncol. 2020. PMID: 33133385 Free PMC article.
-
Disease Burden of Total and Early-Onset Colorectal Cancer in China from 1990 to 2019 and Predictions of Cancer Incidence and Mortality.Clin Epidemiol. 2023 Feb 1;15:151-163. doi: 10.2147/CLEP.S391058. eCollection 2023. Clin Epidemiol. 2023. PMID: 36755975 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources